Coronavirus reproduction blocking drug found in Japan

The results of the study are published on the bioRxiv portal.

The researchers found a decrease in the replication activity of the pathogen COVID-19 after exposure to nelfinavir on virus particles.

“These results show that nelfinavir may be a potential drug for the treatment of COVID-19 and its effectiveness should be tested in patients with coronavirus,” the commentary says.

Earlier, the FMBA of Russia proved the antiviral activity of the drug Mefloquine against the pathogen COVID-19.